Circulating tumor cells as therapy-related biomarkers in cancer patients.
about
Metastasis of circulating tumor cells: favorable soil or suitable biomechanics, or both?Recent developments in prognostic and predictive testing in uveal melanomaDetection of circulating tumor cellsMicrometastatic cancer cells in lymph nodes, bone marrow, and blood: Clinical significance and biologic implicationsA Quest to Identify Prostate Cancer Circulating Biomarkers with a Bench-to-Bedside PotentialCirculating tumor cells in oral squamous cell carcinoma-an enigma or reality?High-Density Dielectrophoretic Microwell Array for Detection, Capture, and Single-Cell Analysis of Rare Tumor Cells in Peripheral BloodLiquid biopsy based biomarkers in non-small cell lung cancer for diagnosis and treatment monitoringTowards the Biological Understanding of CTC: Capture Technologies, Definitions and Potential to Create Metastasis.A Versatile Microarray Platform for Capturing Rare CellsA novel flow cytometry-based cell capture platform for the detection, capture and molecular characterization of rare tumor cells in blood.Monitoring changes in circulating tumour cells as a prognostic indicator of overall survival and treatment response in patients with metastatic melanoma.Current early diagnostic biomarkers of prostate cancerERK-regulated αB-crystallin induction by matrix detachment inhibits anoikis and promotes lung metastasis in vivo.Current challenges for detection of circulating tumor cells and cell-free circulating nucleic acids, and their characterization in non-small cell lung carcinoma patients. What is the best blood substrate for personalized medicine?Randomized controlled phase III trial of adjuvant chemo-immunotherapy with activated killer T cells and dendritic cells in patients with resected primary lung cancer.Circulating and disseminated tumor cells from breast cancer patient-derived xenograft-bearing mice as a novel model to study metastasis.Detection of circulating tumor cells in hepatocellular carcinoma using antibodies against asialoglycoprotein receptor, carbamoyl phosphate synthetase 1 and pan-cytokeratin.Improved method increases sensitivity for circulating hepatocellular carcinoma cells.Triclosan potentiates epithelial-to-mesenchymal transition in anoikis-resistant human lung cancer cellsHeterogeneity of miR-10b expression in circulating tumor cellsEpithelial-to-mesenchymal transition leads to loss of EpCAM and different physical properties in circulating tumor cells from metastatic breast cancer.Analysis of circulating tumor cells in colorectal cancer liver metastasis patients before and after cryosurgeryA novel microfluidic platform for size and deformability based separation and the subsequent molecular characterization of viable circulating tumor cellsMonitoring in metastatic breast cancer: is imaging outdated in the era of circulating tumor cells?Controversies in circulating tumor cell count during therapy.Biopsies: next-generation biospecimens for tailoring therapy.Advances and critical concerns with the microfluidic enrichments of circulating tumor cells.New frontiers in circulating tumor cell analysis: A reference guide for biomolecular profiling toward translational clinical use.Advanced technologies for studying circulating tumor cells at the protein level.Molecular analysis of circulating tumour cells-biology and biomarkers.Squamous cell carcinoma of the oral cavity and circulating tumour cells.Circulating tumor cells as biomarkers of head and neck squamous cell carcinoma: an updated view.Early detection of poor outcome in patients with metastatic colorectal cancer: tumor kinetics evaluated by circulating tumor cells.Detection of circulating tumor cells in patients with esophagogastric or pancreatic adenocarcinoma using the CellSearch(®) system: An observational feasibility study.Shape-dependent optoelectronic cell lysisIsolation, detection, and immunomorphological characterization of circulating tumor cells (CTCs) from patients with different types of sarcoma using isolation by size of tumor cells: a window on sarcoma-cell invasion.Circulating tumor cells in patients with head and neck squamous cell carcinoma: Feasibility of detection and quantitation.Detection of circulating tumor cells from cryopreserved human sarcoma peripheral blood mononuclear cells.Plasma Cell-Free DNA as a Predictive Marker after Radiotherapy for Hepatocellular Carcinoma.
P2860
Q26796595-88BBAE16-CB3E-492B-8567-9197460E5C0EQ26824096-31408407-88D5-4D8F-A0F2-E9B6A8E298E5Q26859334-81A64CF1-71C3-4891-9B5B-1DCD6F1657EFQ26996059-1B17D759-8D43-4642-BFF5-4983360D48B7Q27022638-667F12B7-AAD3-46D4-82BD-0A6DE6254F2CQ27022829-2967E538-F0A7-4ADA-ACC6-E59E97278D63Q27304104-F161F33F-1720-4F4F-B53D-642DAA2D2BACQ28076191-113EB022-8A61-43B4-A203-72C35336A60BQ30445250-D0E7FCCA-FA04-4AD1-834C-20EF92EE0E3BQ30670232-0FB2CD43-F7CF-4876-BBA1-D4ABF1136193Q33741201-CC67F8EA-00C7-4398-A2F4-6DC50A9A254EQ33768350-26BE6774-A9D1-4CA4-90EC-31034B97FCB6Q33922390-E3DD233C-6EB4-46AF-834D-B8E3CB4DC472Q34462869-8A6EA714-D808-4862-8D87-F6339CBA623CQ34577740-5A565085-361B-4DA0-AC47-B7EA6F454685Q34807804-8FCE9214-F9B9-4F02-BF0A-0CA2615C80C7Q35053624-761DC7F7-670D-41BA-900F-45EC91059B13Q35157131-AA4B3D56-BAC7-426F-AD53-CA2A39A6461EQ35169325-DA279A3F-AFB4-4B77-B65A-5C7747364AE1Q35347566-BBB50C5D-BBDB-4D6B-8D04-ABBC59E940FEQ36237785-B2C84AF9-8AE0-44F9-9987-04345FD6BFB7Q37269406-F309B6A6-2188-4D23-AF6E-2382A3E68D8FQ37282976-46221824-FE74-4884-880D-E4334A3978ADQ37349065-FFB2221F-FC01-4C14-8781-B25BDA080279Q37716195-391B7D81-7E8C-427E-B902-69C495DD580CQ38115624-BC8E33D2-96EB-48B1-8A9E-804F676F223BQ38116896-847D0973-D1EA-45EF-BAB5-37172337E9FCQ38131998-5A388035-F751-46B0-B8C9-75BF56CEC05BQ38152315-661D470D-80A5-409D-896D-74F2482AB2C3Q38160932-CAF42D6A-DE53-49DB-BABF-3C0EC1E56BA4Q38180320-62E91852-1932-48D8-9539-D3F54F455F1AQ38211869-4FAE4270-D315-4339-9606-A8BA4D7E6468Q38986172-50514EB0-AF56-43EC-91A5-A23429ECE3ABQ39345874-1F41E788-C4BB-4819-888D-F3F06F209642Q39572125-390712AA-5690-4394-8BC7-4DAE8A8A2CD7Q40967613-AB0C972B-7B2D-451C-B004-1292830F5E1FQ42036216-DD1256BC-8680-4EA8-BE6B-E2DB81482373Q48225558-68C90D64-CF5F-4469-B232-18A3F0D1E38EQ50559927-61D72039-3A6D-4602-9120-BA3FF5C629ACQ55234264-7526454E-42C4-4B07-B76E-F2C26862E5CD
P2860
Circulating tumor cells as therapy-related biomarkers in cancer patients.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Circulating tumor cells as therapy-related biomarkers in cancer patients.
@en
type
label
Circulating tumor cells as therapy-related biomarkers in cancer patients.
@en
prefLabel
Circulating tumor cells as therapy-related biomarkers in cancer patients.
@en
P2860
P1476
Circulating tumor cells as therapy-related biomarkers in cancer patients.
@en
P2093
Klaus Pantel
Tobias M Gorges
P2860
P2888
P304
P356
10.1007/S00262-012-1387-1
P577
2013-01-12T00:00:00Z
P5875
P6179
1039950492